CISPLATIN AND DNA-REPAIR IN CANCER-CHEMOTHERAPY

被引：487

作者：

ZAMBLE, DB

LIPPARD, SJ

机构：

[1] Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139

来源：

TRENDS IN BIOCHEMICAL SCIENCES | 1995年 / 20卷 / 10期

关键词：

D O I：

10.1016/S0968-0004(00)89095-7

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Cisplatin, a DNA-damaging agent, is one of the most widely used anticancer drugs. As with all members of this class of chemotherapeutic compounds, the clinical success of cisplatin is compromised if tumor cells become resistant by various mechanisms, including enhanced DNA repair. In addition to its role in resistance, DNA repair has been linked to the cytotoxic mechanism of cisplatin. DNA damaged by the drug has proved to be a valuable tool for exploring the details of the nucleotide excision repair pathway.

引用

页码：435 / 439

页数：5

共 34 条

[1] THE NUMBER OF PLATINUM ATOMS BINDING TO DNA, RNA AND PROTEIN MOLECULES OF HELA-CELLS TREATED WITH CISPLATIN AT ITS MEAN LETHAL CONCENTRATION
AKABOSHI, M
KAWAI, K
MAKI, H
AKUTA, K
UJENO, Y
MIYAHARA, T
[J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (05): : 522 - 526
[2] ENHANCED REPAIR OF A CISPLATIN-DAMAGED REPORTER CHLORAMPHENICOL-O-ACETYLTRANSFERASE GENE AND ALTERED ACTIVITIES OF DNA-POLYMERASES ALPHA AND BETA, AND DNA-LIGASE IN CELLS OF A HUMAN-MALIGNANT GLIOMA FOLLOWING IN-VIVO CISPLATIN THERAPY
ALIOSMAN, F
BERGER, MS
RAIRKAR, A
STEIN, DE
[J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 54 (01) : 11 - 19
[3] THE XPA PROTEIN IS A ZINC METALLOPROTEIN WITH AN ABILITY TO RECOGNIZE VARIOUS KINDS OF DNA-DAMAGE
ASAHINA, H
KURAOKA, I
SHIRAKAWA, M
MORITA, EH
MIURA, N
MIYAMOTO, I
OHTSUKA, E
OKADA, Y
TANAKA, K
[J]. MUTATION RESEARCH-DNA REPAIR, 1994, 315 (03): : 229 - 237
[4] EFFECT OF CIS-PLATINUM (II) DIAMMINODICHLORIDE ON WILD-TYPE AND DEOXYRIBONUCLEIC ACID REPAIR-DEFICIENT MUTANTS OF ESCHERICHIA-COLI
BECK, DJ
BRUBAKER, RR
[J]. JOURNAL OF BACTERIOLOGY, 1973, 116 (03) : 1247 - 1252
[5] HMG DOMAIN PROTEINS INDUCE SHARP BENDS IN CISPLATIN-MODIFIED DNA
CHOW, CS
WHITEHEAD, JP
LIPPARD, SJ
[J]. BIOCHEMISTRY, 1994, 33 (50) : 15124 - 15130
[6] CHU G, 1994, J BIOL CHEM, V269, P787
[7] DETERMINANTS OF CISPLATIN SENSITIVITY IN NONMALIGNANT NON-DRUG-SELECTED HUMAN T-CELL LINES
DABHOLKAR, M
PARKER, R
REED, E
[J]. MUTATION RESEARCH, 1992, 274 (01): : 45 - 56
[8] ERCC1 AND ERCC2 EXPRESSION IN MALIGNANT-TISSUES FROM OVARIAN-CANCER PATIENTS
DABHOLKAR, M
BOSTICKBRUTON, F
WEBER, C
BOHR, VA
EGWUAGU, C
REED, E
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (19) : 1512 - 1517
[9] DIJT FJ, 1988, CANCER RES, V48, P6058
[10] FAN SJ, 1995, CANCER RES, V55, P1649

← 1 2 3 4 →